| Add to balance / Manage account | User: | Log out |
| Prospect News home > News index > List of issuers K > Headlines for K-V Pharmaceutical Co. > News item |
K-V Pharmaceutical operating income declines to $127,000 in January
By Caroline Salls
Pittsburgh, Feb. 15 - K-V Pharmaceutical Co. reported $127,000 of operating income for January on $7.02 million of net revenues, according to its monthly operating report filed Friday with the U.S. Bankruptcy Court for the Southern District of New York.
In comparison, K-V posted $1.46 million of operating income for December on $6.98 million of net revenues.
The net loss from continuing operations for January was $3.25 million, compared with a $33.1 million net income from continuing operations for December.
In addition, K-V had $33.54 million in cash and cash equivalents at Jan. 31, down from $34.88 million at the end of December.
K-V Pharmaceutical, a St. Louis specialty pharmaceutical company, filed for bankruptcy on Aug. 4. The Chapter 11 case number is 12-13346.
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.